Last reviewed · How we verify
NCT02346097: ElectroCRT
Electrophysiological Optimization of Left Ventricular Lead Placement in CRT
NA trial testing Cardiac Resynchronization Therapy (St. Jude Qaudripolar LV lead) in Congestive Heart Failure in 122 participants. Completed in 7 June 2018.
7 June 2018
Quick facts
| Lead sponsor | University of Aarhus |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 122 |
| Start date | 16 February 2015 |
| Primary completion | 7 June 2018 |
| Estimated completion | 7 June 2018 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Cardiac Resynchronization Therapy (St. Jude Qaudripolar LV lead)
Conditions studied
- Congestive Heart Failure — all drugs for Congestive Heart Failure →
Sponsor
University of Aarhus
Who can join
40 and older, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate if "optimal electrical resynchronization" achieved by targeting left ventricular lead placement to the myocardial region with the latest electrical activation combined with post-implant pacemakersettings for narrowing the paced QRS width causes an excess improvement in the pumping function of the heart (the left ventricular ejection fraction) in Cardiac Resynchronization Therapy (CRT)
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The role of guidance in delivering cardiac resynchronization therapy: A systematic review and network meta-analysis.
Mehta VS, Ayis S, Elliott MK, Widjesuriya N, et al · · 2022 · cited 6× · PMID 36340494 · DOI 10.1016/j.hroo.2022.07.005 -
Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT).
Stephansen C, Sommer A, Kronborg MB, Jensen JM, et al · · 2018 · cited 6× · PMID 30382923 · DOI 10.1186/s13063-018-2930-y
Verify or expand the search:
- PubMed search for NCT02346097
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Congestive Heart Failure
Currently open trials in the same condition.
- NCT07008365 — The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure · Phase 3 · recruiting
- NCT06526884 — Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) · NA · active not recruiting
- NCT06495892 — PVP-Guided Decongestive Therapy in HF 2 · Phase 4 · recruiting
- NCT06374277 — Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence · NA · recruiting
- NCT05971225 — Verifying Remote Monitoring Effect on Net Cardiovascular Outcome; RemoteVerify (RêVe) · NA · recruiting
Other University of Aarhus trials
Trials by the same sponsor.
- NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
- NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
- NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02346097 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
- Last refreshed: 18 June 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02346097.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing